Clorox

Current directors and officers who also hold a role at another S&P 500 company.

• Christopher J. WilliamsAMP · DirectorUNP · Director
• Pierre R. BreberPCAR · DirectorLUV · Director
• Stephen B. BratspiesTGT · DirectorYUM · Director
• Linda J. RendleV · Director
• Russell J. WeinerDPZ · CEO

Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.

No 5% holder filings parsed yet for this company.

Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.

Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.

1. Oct 29, 2026

   On October 28, 2026, the Board of Directors (the “Board”) of The Clorox Company (the “Company”), appointed Fabian Garcia to serve as the Chief Executive Officer (“CEO”) of the Company and a member of the Board, effective as of January 5, 2027 (the “Effective Date”). Linda Rendle will step down from her role as CEO of the Company and Chair and a member of the Board as of the Effective Date and will serve as a senior advisor to the Company through April 2, 2027, to assist with transition matters. As of the Effective Date, Matthew J. Shattock, currently Lead Independent Director of the Board, will serve as Independent Chair of the Board. In connection with this role, Mr. Shattock will receive an Independent Chair retainer of $225,000 in addition to the annual director retainer and annual grant of deferred stock units, each paid in line with our non-employee director compensation practices.

   Read the 8-K filing
2. Jun 17, 2026

   On June 14, 2026, the Management Development and Compensation Committee (the “MDCC”) of the Board of Directors of The Clorox Company (the “Company”) appointed Chris Hyder, age 51, to be Executive Vice President and Chief Operating Officer (“COO”) effective June 17, 2026. Information on Mr. Hyder’s previous roles can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 filed with the SEC on August 8, 2025 (the “2025 10-K”) and is hereby incorporated into this

   Read the 8-K filing
3. May 28, 2026

   (b) On May 26, 2026, Linda Rendle, Chair of the Board of Directors (the “Board”) and Chief Executive Officer (“CEO”) of The Clorox Company (the “Company”), asked the Board to initiate a CEO search process, as she has made the decision to step down for health reasons. Ms. Rendle will remain as Chair and CEO while the search is conducted and until the new CEO is appointed. Ms. Rendle will also serve in an advisory role for a period following the appointment to drive business performance and a smooth leadership transition.

   Read the 8-K filing
4. Oct 30, 2025

   (b) On October 27, 2025, Eric Reynolds, Executive Vice President – Chief Operating and Strategy Officer of The Clorox Company (the “Company”), provided notice of his intention to resign from the Company, following 27 years of service. He will step down from his role effective December 2, 2025, and will be available on an advisory basis as needed through February 2, 2026. The Company does not expect to appoint a replacement for Mr. Reynolds. 2

   Read the 8-K filing
5. May 12, 2025

   On May 11, 2025, the Board of Directors (the “Board”) of The Clorox Company (the “Company”) elected Gina Boswell to the Board, effective May 19, 2025. In addition, the Board appointed Ms. Boswell to the Nominating, Governance and Corporate Responsibility Committee of the Board, effective May 19, 2025. Ms. Boswell will be provided with the Company’s standard non-employee director compensation and director indemnification agreement. A press release announcing the election of Ms. Boswell is filed as Exhibit 99.1 and is incorporated herein in its entirety.

   Read the 8-K filing
6. Jan 28, 2025

   (b) On January 23, 2025, Kevin Jacobsen, Executive Vice President – Chief Financial Officer of The Clorox Company (the “Company”), provided notice of his intention to retire from the Company effective April 1, 2025, following nearly 30 years of service. Mr. Jacobsen will continue in an advisory capacity at the Company until June 2025. (c) On January 23, 2025, the Management Development and Compensation Committee (the “MDCC”) of the Board of Directors of the Company appointed Luc Bellet, age 46, to be Executive Vice President – Chief Financial Officer, effective April 1, 2025. Mr. Bellet is currently the Company’s Vice President – Treasurer, a position he has held since October 2023. Prior to this role, Mr. Bellet served as Vice President – Financial Planning & Analysis from April 2018 to October 2023. Mr.

   Read the 8-K filing
7. Jul 26, 2023

   (b) On July 24, 2023, Rebecca Dunphey, Group President – Care & Connection of The Clorox Company (the “Company”), provided notice of her intention to resign from the Company effective August 11, 2023. The Company announced that Dan Dahlgren, a long-time Clorox executive who retired last year, will return to the Company to provide interim leadership to the Company’s Care & Connection group. The Company also announced that it has initiated a search to permanently fill the vacancy resulting from Ms. Dunphey’s departure.

   Read the 8-K filing
8. May 18, 2022

   On May 13, 2022, the Board of Directors (the “Board”) of The Clorox Company (the “Company”) elected Julia (Charter) Denman and Stephanie Plaines to the Board, each effective as of May 16, 2022. It is expected that both Ms. Denman and Ms. Plaines will be appointed to the Audit Committee at the Board meeting in September 2022. Each of Ms. Denman and Ms. Plaines will be provided with the Company’s standard non-employee director compensation and director indemnification agreement. A press release announcing the election of Ms. Denman and Ms. Plaines is filed as Exhibit 99.1 and is incorporated herein in its entirety.

   Read the 8-K filing
9. Mar 2, 2022

   (b) On March 2, 2022, The Clorox Company (the “Company”) announced that Tony Matta, Executive Vice President – Chief Growth Officer of the Company, would be leaving the Company, effective March 11, 2022. In addition, the Company announced that Stacey Grier, currently Senior Vice President – Chief Marketing and Strategy Officer, is being promoted to the role of Executive Vice President – Chief Growth & Strategy Officer, effective March 14, 2022.

   Read the 8-K filing
10. Nov 17, 2021

    On November 17, 2021, The Clorox Company (the “Company”) held its 2021 Annual Meeting of Shareholders, at which the Company’s shareholders approved the Company’s 2005 Stock Incentive Plan, as amended and restated (the “Plan”), which provides for the grant of equity-based awards to employees, directors and consultants of the Company. The material terms of the Plan are summarized in the Company’s Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission on October 6, 2021. The foregoing and the description of the Plan as contained herein is qualified in its entirety by reference to the full text of the Plan, which is included as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference into this

    Read the 8-K filing
11. Apr 8, 2021

    (b) On April 5, 2021, Jeffrey R. Baker, Vice President - Chief Accounting Officer and Corporate Controller of The Clorox Company (the “Company”), provided notice of his intention to resign from the Company effective as of April 30, 2021. (c) On April 6, 2021, the Management Development and Compensation Committee (the “MDCC”) of the Board of Directors of the Company appointed Laura Peck, age 44, as Vice President - Chief Accounting Officer & Corporate Controller, effective May 3, 2021, replacing Mr. Baker as Principal Accounting Officer as of the effective date of her appointment. Ms. Peck is currently the Company’s Vice President – Accounting, a position she has held since August 2019. In this role, she is responsible for the Company’s external financial reporting process, consolidation of the Company’s financial results, and accounting policy and operations. Ms.

    Read the 8-K filing
12. Jan 28, 2021

    On January 25, 2021, Benno Dorer notified the board of directors (the “Board”) of The Clorox Company (the “Company”) that he is resigning from the Board effective February 15, 2021. Mr. Dorer served as chief executive officer of the Company from November 2014 to September 2020, and was appointed chair of the Board in August 2016. He has continued to serve as the Board’s executive chair since September 2020. On January 27, 2021, the independent members of the Board appointed Matthew Shattock as Independent Chair of the Board, effective February 15, 2021. In addition, Pamela Thomas-Graham notified the Company on January 25, 2021, that she has decided not to stand for re-election to the Board at the end of her current term, which ends in November 2021. Further, in connection with Mr. Shattock’s appointment as independent chair, Ms. Thomas-Graham will step down as lead independent director.

    Read the 8-K filing
13. Nov 19, 2020

    (b) On November 16, 2020, Laura Stein, Executive Vice President – General Counsel and Corporate Affairs of The Clorox Company (the “Company”), provided notice of her intention to resign from the Company effective December 11, 2020, following over 23 years of service with the Company. On November 19, 2020, the Company announced that Angela Hilt, currently Vice President – Corporate Secretary & Deputy General Counsel, would be promoted to the role of Senior Vice President – Chief Legal Officer effective December 14, 2020.

    Read the 8-K filing
14. Aug 12, 2020

    (c) On August 11, 2020, Eric Reynolds, age 50, was elected as executive vice president - chief operating officer of The Clorox Company (the “Company”), effective September 14, 2020. Mr. Reynolds has served as the Company’s executive vice president – household and lifestyle since July 2019 and prior to that was executive vice president – cleaning and Burt’s Bees from January 2019 to July 2019. From January 2015 to January 2019, he served as senior vice president – chief marketing officer. He served as vice president – general manager, Europe, Middle East, Africa and Asia from May 2012 to January 2015. From May 2011 to April 2012, he was director, international business development. From June 2008 to April 2011, he was general manager, Caribbean. Mr. Reynolds joined the Company in 1998.

    Read the 8-K filing
15. Aug 3, 2020

    (b), (c), (d) On August 1, 2020, the Board of Directors (the “Board”) of The Clorox Company (the “Company”) elected Linda Rendle, a 17-year veteran of the Company, chief executive officer and a member of the Company’s board of directors, effective September 14, 2020. Benno Dorer, the Company’s current chief executive officer, notified the Board on July 31, 2020 that he will step down from the role effective September 14, 2020. Mr. Dorer will continue to serve as the Board’s executive chair. Ms. Rendle, 42, has served as the Company’s president since May 2020 and prior to that was executive vice president- cleaning, international, strategy and operations since July 2019. Ms. Rendle previously served as executive vice president – strategy and operations from January 2019 to July 2019. From June 2018 to January 2019, she served as executive vice president – cleaning and strategy.

    Read the 8-K filing

Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021

From the company's 10-K XBRL data (SEC companyfacts).

People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.